17th Summit on Biosimilars & Innovator Biologics
June 2-3, 2026
New York
American Conference Institute (ACI)
Finnegan partner Jeffrey Jacobstein will join the panel discussion “Manufacturing Patents as the New Battleground: Protecting Biologics Manufacturing” at the American Conference Institute (ACI) Summit on Biosimilars & Innovator Biologics. The conference will take place at 3 Times Square in New York, New York. For more information, or to register, please see the ACI’s website.
